SAN DIEGO --(BUSINESS WIRE)--Oct. 27, 2020-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2020 . Third Quarter 2020 Financial Highlights:   Revenue grew 26% versus the same quarter of the prior year to $500.9 million U.S.

SAN DIEGO --(BUSINESS WIRE)--Oct. 26, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that Rick Doubleday , Executive Vice President and Chief Commercial Officer, will retire at the end of 2020 in order to spend more time with his family. Rick joined Dexcom in 2009 and has built a world-class

SAN DIEGO --(BUSINESS WIRE)--Oct. 13, 2020-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Kyle Malady to its Board of Directors, effective immediately. Mr. Malady currently serves as executive vice president of global

SAN DIEGO --(BUSINESS WIRE)--Oct. 1, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2020 financial results after market close on Tuesday, October 27, 2020 . Management will hold a conference call to review the company's third quarter 2020 performance

SAN DIEGO --(BUSINESS WIRE)--Sep. 24, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced it has signed a five-year collaboration agreement with the University of Virginia to advance its research and development efforts on continuous glucose monitoring-based solutions.

Data could support future efforts to make real-time CGM a standard tool for glycemic assessment in the hospital setting Real-world evidence will be gathered from healthcare providers and hospital institutions using real-time CGM with hospitalized patients SAN DIEGO --(BUSINESS WIRE)--Sep.

SAN DIEGO --(BUSINESS WIRE)--Sep. 4, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences: Steve Pacelli , Executive Vice President Strategy and Corporate Development, and Jereme Sylvain , Senior

SAN DIEGO --(BUSINESS WIRE)--Aug. 12, 2020-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Karen Dahut to its Board of Directors, effective immediately. Ms. Dahut has more than 25 years of leadership experience in

SAN DIEGO --(BUSINESS WIRE)--Aug. 10, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Quentin Blackford , Chief Operating Officer and Chief Financial Officer, and Steve Pacelli , Executive Vice

SAN DIEGO --(BUSINESS WIRE)--Jul. 28, 2020-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2020 . Second Quarter 2020 Financial Highlights: Revenue grew 34% versus the same quarter of the prior year to $451.8 million U.S.